Medlab is a disruptive, Australian headquartered, Biotechnology company currently listed on the ASX, whilst undergoing dual listing to Nasdaq.
At the core of what Medlab does and whom it serves, Medlab focuses on the use of delivery platforms to enhance medicines specifically for those patients not adequately treated by standard care (unmet needs).
At the core of what Medlab does and whom it serves, Medlab focuses on the use of delivery platforms to enhance medicines specifically for those patients not adequately treated by standard care (unmet needs).
Ticker:
MDC
Exchange:
ASX
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Australia
Year Founded:
2015
Main Therapeutic Focus:
Platform for Therapeutics
Lead Product in Development:
NanoCelle
Development Phase of Primary Product:
Multiple Products in Market
Number Of Unlicensed Products (For Which You Are Seeking Partners):
3
Speaker
